MULTAQ 400 400mg film-coated tablets medication leaflet

C01BD07 dronedarone • Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class III

Dronedarone is an antiarrhythmic medication used for the treatment of paroxysmal or persistent atrial fibrillation, aiming to maintain normal sinus rhythm. It works by blocking potassium, sodium, and calcium channels, stabilizing the heart's electrical activity.

The medication is taken orally, usually twice daily, as directed by a doctor. It is important to monitor cardiac and liver function during treatment.

Side effects may include nausea, diarrhea, fatigue, or skin rash. In rare cases, liver failure or worsening arrhythmias may occur.

Dronedarone is not recommended for patients with severe heart failure, liver failure, or hypersensitivity to this medication.

General data about MULTAQ 400 400mg

Substance: dronedarone

Date of last drug list: 01-04-2015

Commercial code: W55155003

Concentration: 400mg

Pharmaceutical form: film-coated tablets

Quantity: 60

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Other substances similar to dronedarone